Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001231919-25-000232
Filing Date
2025-09-23
Accepted
2025-09-23 16:21:23
Documents
1
Period of Report
2025-09-19

Document Format Files

Seq Description Document Type Size
1 form4-09232025_080918.html 4  
1 form4-09232025_080918.xml 4 22447
  Complete submission text file 0001231919-25-000232.txt   24678
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Issuer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014
Business Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014 646-597-6980
RTW INVESTMENTS, LP (Reporting) CIK: 0001493215 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36829 | Film No.: 251333873

Mailing Address C/O RTW INVESTMENTS, LP 40 10TH AVENUE, 7TH FLOOR NEW YORK NY 10014
Business Address
WONG RODERICK (Reporting) CIK: 0001493280 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36829 | Film No.: 251333872